Koninklijke Philips reported EUR3.75B in Operating Expenses for its fiscal quarter ending in June of 2026.





Operating Expenses Change Date
Abbott USD 11.66B 1.2B Sep/2026
Baxter International USD 6.5B 3.82B Sep/2026
Becton, Dickinson and Co. USD 4.16B 20.25B Sep/2026
Boston Scientific USD 4.13B 72M Sep/2026
Danaher USD 53.62B 1.04B Sep/2026
Demant DKK 10.79B 1.16B Jun/2026
Dexcom USD 990.1M 53.5M Jun/2026
Edwards Lifesciences USD 10.86B 9.64B Sep/2026
Fresenius EUR 5.24B 19M Sep/2026
General Electric Aerospace USD 17.52B 118M Sep/2026
Getinge SEK 7.03B 2.96B Jun/2026
Globus Medical USD 585.49M 250.09M Sep/2026
GN Store Nord DKK 1.96B 156M Sep/2026
Hitachi JPY 2.56T 140.17B Sep/2026
Idexx Laboratories USD 811.89M 20.87M Sep/2026
Insulet USD 652.2M 19.8M Sep/2026
Integra LifeSciences USD 368.53M 674.84M Sep/2026
Intuitive Surgical USD 2B 86.5M Sep/2026
J&J USD 18.93B 1.09B Sep/2026
Koninklijke Philips EUR 3.75B 86M Jun/2026
Medtronic USD 7.92B 203M Jun/2026
Philips EUR 4.23B 478M Sep/2026
ResMed USD 1.01B 83.57M Jun/2026
Smith & Nephew USD 2.59B 71M Jun/2026
Steris USD 1.27B 62.5M Sep/2026
Stryker USD 4.8B 118M Jun/2026
Teleflex USD 3.49B 589.18M Sep/2026
Terumo JPY 331.37B 109.04B Sep/2026
Zimmer Biomet Holdings USD 1.72B 110.9M Sep/2026